Stock screenerAll disclosures →
EDGAR →
CMPS
Conviction 94HealthcareScan · Thu, Jun 25, 2026Bullish marubozu
CMPS$13.60+8.07%
ResistanceSupportVol 14Vol MA14 3.2M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price13.60
Change+8.07%
Gap+1.35%
Rel volume1.68×
Avg volume3.65M
Avg $ vol46.08M
SMA 2012.35
SMA 5010.68
SMA 2007.35
Price vs 50+27.26%
Price vs 200+84.92%
MA stackbullish
50/200 cross—
Supertrenddown · 13.98
RSI (14)65
MACD hist0.01
MACD crossbull · 0d
Stoch %K / %D99 / 74
ADX (14)32
+DI / −DI32 / 16
RSI divergence—
MACD divergence—
ATR %+6.65%
ADR %7.77%
52w high14.19
52w low2.66
From 52w high-4.19%
Above 52w low+411.09%
New 52w highNo
SqueezeOff
Bollinger width26.10%
%B0.89
Donchian pos71.13%
Donchian high14.76
Donchian low10.72
AVWAP (52w high)12.65
vs AVWAP high+7.49%
AVWAP (52w low)7.52
vs AVWAP low+80.81%
OBV trendUp
Chaikin MF (20)0.03
Today vs 20d1.68×
Avg vol (14d)3.2M
Avg vol (20d)3.65M
Avg $ vol (20d)46.08M
Market cap1.83B
RS 3m (vs SPY)+128.74%
RS 6m (vs SPY)+89.75%
RS line new highNo
Trend template8/8
Technical rank94.8
1 week+13.86%
1 month+11.21%
3 months+141.90%
6 months+108.19%
1 year+437.35%
YTD+107.56%
P/E-6.37
P/B5.62
P/S—
P/FCF-11.67
EPS-3.08
Div yield—
ROE-88.12%
ROA-54.14%
Debt/Eq0.15
Current3.32
EV/EBITDA-7.94
Gross margin—
Net margin—
Rev growth—
EPS growth-85.57%
Price target24.36
Target upside79.18%
Analyst ratingBuy
Institutional70.83%
Ent. value1.42B
Revenue—
Net income91.2M
Gross profit—
Free cash flow-157.24M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out134.95M
Employees156
ListedFri, Sep 18, 2020
Free float18.91M
Float %14.0%
Short interest7.33M
Days to cover1.7d
Short volume27.3%
Squeeze score59 / 100
Next earningsThu, Jul 30, 2026 (35d)
EPS forecast−$0.46 · 6 est
Last EPS vs est−$0.30 vs −$0.45
Last surprise+33.3% beat
Setup gradeA+
Conviction94 / 100
Pattern quality—
Tech rank94.8 / 100
Group rank50 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish marubozu
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CMPS
No recent disclosed trades by Congress in CMPS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CMPS · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Riley Wayne Joseph Director · Share Option (Right to Buy) · 2026-05-27 | Grant | 21.11K | $0 | 2026-05-27 | 2026-05-29 |
Tregoning Kathleen Director · Share Option (Right to Buy) · 2026-05-27 | Grant | 41.12K | $0 | 2026-05-27 | 2026-05-29 |
JONAS JEFFREY M Director · Share Option (Right to Buy) · 2026-05-27 | Grant | 21.11K | $0 | 2026-05-27 | 2026-05-29 |
Gover Justin D. Director · Share Option (Right to Buy) · 2026-05-27 | Grant | 21.11K | $0 | 2026-05-27 | 2026-05-29 |
Norton David Y Director · Share Option (Right to Buy) · 2026-05-27 | Grant | 21.11K | $0 | 2026-05-27 | 2026-05-29 |
McQuade Robert Director · Share Option (Right to Buy) · 2026-05-27 | Grant | 21.11K | $0 | 2026-05-27 | 2026-05-29 |
SANTINI GINO Director · Share Option (Right to Buy) · 2026-05-27 | Grant | 30.16K | $0 | 2026-05-27 | 2026-05-29 |
Karydas Daphne Director · Share Option (Right to Buy) · 2026-05-27 | Grant | 21.11K | $0 | 2026-05-27 | 2026-05-29 |
SEC filings
EDGAR filings in CMPS
No recent SEC filings on file for CMPS.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.